Presented by Alliance for Aging Research {beacon} Health Care Health Care PRESENTED BY The Big Story Vaccine advisers to ...

The U.S. Department of Agriculture (USDA) will potentially announce a plan to vaccinate poultry against highly pathogenic ...

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...

In a study of newborn piglets, infection with influenza A was associated with disruptions in the piglets' nasal and gut ...

The latest edition of Poultry World is available online. In this edition we visit a former investment banker who had built a ...

Cidara Therapeutics' shares were set to rally at the opening bell after a trial of the biotechnology company's non-vaccine preventative of seasonal influenza met all key goals. In premarket trading, ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

For the first time since the start of the COVID-19 pandemic, the number of Nova Scotians dying from influenza exceeds that of ...

The approval was based on data from the pivotal Phase IIb/III CLEVER trial which assessed a single dose of the antibody.

Two Lottery players have cause for celebration after purchasing winning tickets this weekend in the Twin Cities.

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.